Allarity Therapeutics Stock Buy Hold or Sell Recommendation
| ALLR Stock | USD 1.27 0.01 0.79% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Allarity Therapeutics is 'Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Allarity Therapeutics given historical horizon and risk tolerance towards Allarity Therapeutics. When Macroaxis issues a 'buy' or 'sell' recommendation for Allarity Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Allarity Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Allarity Stock, please use our How to Invest in Allarity Therapeutics guide. Note, we conduct extensive research on individual companies such as Allarity and provide practical buy, sell, or hold advice based on investors' constraints. Allarity Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Allarity |
Execute Allarity Therapeutics Buy or Sell Advice
The Allarity recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Allarity Therapeutics. Macroaxis does not own or have any residual interests in Allarity Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Allarity Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Very Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Hold | Details | |
Financial Strenth (F Score) | Very Weak | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Allarity Therapeutics Trading Alerts and Improvement Suggestions
| Allarity Therapeutics generated a negative expected return over the last 90 days | |
| Allarity Therapeutics has high historical volatility and very poor performance | |
| Allarity Therapeutics may become a speculative penny stock | |
| Allarity Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Allarity Therapeutics currently holds 1.3 M in liabilities with Debt to Equity (D/E) ratio of 0.11, which may suggest the company is not taking enough advantage from borrowing. Allarity Therapeutics has a current ratio of 0.86, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Allarity Therapeutics' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (11.9 M) with loss before overhead, payroll, taxes, and interest of (36.35 M). | |
| Allarity Therapeutics currently holds about 7.73 M in cash with (12.74 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.75. | |
| Allarity Therapeutics has a very weak financial position based on the latest SEC disclosures | |
| Roughly 12.0% of Allarity Therapeutics shares are held by company insiders | |
| Latest headline from thelincolnianonline.com: Allarity Therapeutics Provides Corporate Update in Recent Press Release |
Allarity Therapeutics Returns Distribution Density
The distribution of Allarity Therapeutics' historical returns is an attempt to chart the uncertainty of Allarity Therapeutics' future price movements. The chart of the probability distribution of Allarity Therapeutics daily returns describes the distribution of returns around its average expected value. We use Allarity Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Allarity Therapeutics returns is essential to provide solid investment advice for Allarity Therapeutics.
| Mean Return | -1.85 | Value At Risk | -16.11 | Potential Upside | 10.85 | Standard Deviation | 7.42 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Allarity Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Allarity Stock Institutional Investors
The Allarity Therapeutics' institutional investors refer to entities that pool money to purchase Allarity Therapeutics' securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Virtu Financial Llc | 2024-06-30 | 265.3 K | Ubs Group Ag | 2024-06-30 | 41.2 K | Hrt Financial Llc | 2024-06-30 | 34.7 K | Jane Street Group Llc | 2024-06-30 | 15.7 K | Tower Research Capital Llc | 2024-06-30 | 12.2 K | Bank Of America Corp | 2024-06-30 | 145 | Headlands Technologies Llc | 2024-09-30 | 0.0 | Jump Financial Llc | 2024-09-30 | 0.0 | Geode Capital Management, Llc | 2024-09-30 | 0.0 | Citadel Advisors Llc | 2024-06-30 | 0.0 |
Allarity Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Allarity Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Allarity Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Allarity stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -1.99 | |
β | Beta against Dow Jones | 1.03 | |
σ | Overall volatility | 7.46 | |
Ir | Information ratio | -0.27 |
Allarity Therapeutics Volatility Alert
Allarity Therapeutics is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Allarity Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Allarity Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Allarity Therapeutics Fundamentals Vs Peers
Comparing Allarity Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Allarity Therapeutics' direct or indirect competition across all of the common fundamentals between Allarity Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Allarity Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Allarity Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Allarity Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Allarity Therapeutics to competition |
| Fundamentals | Allarity Therapeutics | Peer Average |
| Return On Equity | -1.22 | -0.31 |
| Return On Asset | -0.48 | -0.14 |
| Current Valuation | (11.5 M) | 16.62 B |
| Shares Outstanding | 1.41 M | 571.82 M |
| Shares Owned By Insiders | 12.30 % | 10.09 % |
| Shares Owned By Institutions | 1.20 % | 39.21 % |
| Number Of Shares Shorted | 179.44 K | 4.71 M |
| Price To Book | 0.43 X | 9.51 X |
| Gross Profit | (36.35 M) | 27.38 B |
| EBITDA | (12.08 M) | 3.9 B |
| Net Income | (11.9 M) | 570.98 M |
| Cash And Equivalents | 7.73 M | 2.7 B |
| Cash Per Share | 0.75 X | 5.01 X |
| Total Debt | 1.3 M | 5.32 B |
| Debt To Equity | 0.11 % | 48.70 % |
| Current Ratio | 0.88 X | 2.16 X |
| Book Value Per Share | 16.98 X | 1.93 K |
| Cash Flow From Operations | (12.74 M) | 971.22 M |
| Short Ratio | 0.30 X | 4.00 X |
| Earnings Per Share | (10.98) X | 3.12 X |
| Target Price | 5.0 | |
| Number Of Employees | 5 | 18.84 K |
| Beta | 0.29 | -0.15 |
| Market Capitalization | 2.06 M | 19.03 B |
| Total Asset | 11.86 M | 29.47 B |
| Retained Earnings | (94.45 M) | 9.33 B |
| Working Capital | (12.2 M) | 1.48 B |
| Net Asset | 11.86 M |
Note: Disposition of tradable shares by Alexander Epshinsky of Allarity Therapeutics subject to Rule 16b-3 [view details]
Allarity Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Allarity . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Allarity Therapeutics Buy or Sell Advice
When is the right time to buy or sell Allarity Therapeutics? Buying financial instruments such as Allarity Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Allarity Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Airlines Thematic Idea Now
Airlines
Domestic and international airlines and airline services. The Airlines theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Airlines Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Allarity Stock Analysis
When running Allarity Therapeutics' price analysis, check to measure Allarity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allarity Therapeutics is operating at the current time. Most of Allarity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Allarity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Allarity Therapeutics' price. Additionally, you may evaluate how the addition of Allarity Therapeutics to your portfolios can decrease your overall portfolio volatility.